| Comparison of the pharmacokinetics and safety of three formulations of infliximab (CT-P13, EU-approved reference infliximab and the US-licensed reference infliximab) in healthy … W Park, SJ Lee, J Yun, DH Yoo Expert Review of Clinical Immunology 11 (sup1), 25-31, 2015 | 48 | 2015 |
| Purification and characterization of poly (3-hydroxybutyrate) depolymerase from a fungal isolate, Emericellopsis minima W2 YH Rhee, DY Kim, JH Yun, HW Kim, KS Bae Journal of Microbiology 40 (2), 129-133, 2002 | 42 | 2002 |
| LC-MS determination and bioavailability study of imidapril hydrochloride after the oral administration of imidapril tablets in human volunteers JH Yun, JH Myung, HJ Kim, S Lee, JS Park, W Kim, EH Lee, CJ Moon, ... Archives of pharmacal research 28, 463-468, 2005 | 13 | 2005 |
| Preparation of amorphous form of cefuroxime axetil using supercritical fluid processing GH Jo, JH Yu, JH Yun, SJ Hwang, JS Woo Controlled Release Society 29th Annual Meeting Proceedings, 20-25, 2002 | 9 | 2002 |
| FRI0119 What Intrinsic and Extrinsic Factors Affect the Developement of Anti-Drug Antibody to Innovator Infliximab and its Biosimilar CT-P13 in Rheumatoid Arthritis and … J Braun, W Park, DH Yoo, CH Suh, SC Shim, SJ Lee, SY Lee, JH Yun, ... Annals of the Rheumatic Diseases 74 (Suppl 2), 463-464, 2015 | 5 | 2015 |
| A Randomized, Double-Blind, Three-Arm, Parallel Group, Single-Dose Study to Compare the Pharmacokinetics, Safety, and Tolerability of Three Formulations of Infliximab (CT-P13 … DH Yoo, W Park, SC Shim, CH Suh, J Yun, T Pyo ARTHRITIS & RHEUMATOLOGY 66, S664-S664, 2014 | 5 | 2014 |
| Quantitative determination of imidapril hydrochloride in plasma by LC/MS after oral administration of Tanatril capsule in human volunteers JH Yun, SJ Hwang, HJ Kim, KH Yoon, W Kim, JS Park, CJ Moon, EH Lee The Korean Society of Pharmaceutics 33th Annual Convention, 244, 2003 | | 2003 |
